Gastroenterology & Hepatology

Gastroenterology & Hepatology Gastroenterology & Hepatology (G&H) is a monthly peer-reviewed journal distributed to approximately 18,000 gastroenterologists and hepatologists.

G&H provides editorial content encompassing a wide array of topics relevant and useful to the fields of gastroenterology and hepatology, both separately and together. Content is directed by the strong input of today’s top thought leaders in gastroenterology & hepatology, including thought leader–driven, feature-length review articles, monthly columns comprising engaging interviews with experts on current issues in inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), hepatitis, and endoscopy. G&H also publishes industry-supported Meeting Highlights, Clinical Roundtable Monographs, and Clinical Review Supplements. Both the journal and all affiliated supplements are included in the National Library of Medicine’s PubMed/MEDLINE index as well as EMBASE.

Operating as usual

Drs Kevin Liu, Thomas Enke, and Aziz Aadam discuss the landscape of current and potential future endoscopic therapies fo...
09/28/2020
Endoscopic Approaches to Gastroparesis – Gastroenterology & Hepatology

Drs Kevin Liu, Thomas Enke, and Aziz Aadam discuss the landscape of current and potential future endoscopic therapies for gastroparesis. https://buff.ly/3mLt25U

Gastroenterology & Hepatology September 2020 - Volume 16, Issue 9 Endoscopic Approaches to Gastroparesis Kevin Liu, MD, Thomas Enke, MD, and Aziz Aadam, MD Kevin Liu, MD Division of Gastroenterology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois Thom...

Drs Sara Lewin and Fernando S. Velayos provide readers with standardized daily checklists for treating inpatients with m...
09/25/2020
Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease – Gastroenterology & Hepatology

Drs Sara Lewin and Fernando S. Velayos provide readers with standardized daily checklists for treating inpatients with moderate to severe IBD. https://buff.ly/3mGMiSc

Gastroenterology & Hepatology September 2020 - Volume 16, Issue 9 Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease Sara Lewin, MD, and Fernando S. Velayos, MD, MPH Sara Lewin, MD Division of Gastroenterology; University of California, San Francisco; San Franc...

Q&A with Dr Heiko Pohl: Polypectomy and the efficacy and safety of postpolypectomy clipping. https://buff.ly/3iUjaom
09/24/2020
Polypectomy and the Efficacy and Safety of Postpolypectomy Clipping – Gastroenterology & Hepatology

Q&A with Dr Heiko Pohl: Polypectomy and the efficacy and safety of postpolypectomy clipping. https://buff.ly/3iUjaom

Gastroenterology & Hepatology September 2020 - Volume 16, Issue 9 Polypectomy and the Efficacy and Safety of Postpolypectomy Clipping Heiko Pohl, MD Associate Professor of Medicine Geisel School of Medicine at Dartmouth Hanover, New Hampshire Department of Gastroenterology, Dartmouth-Hitchcock Medic...

Dr K. Rajender Reddy discusses the effects of the COVID-19 pandemic on liver transplantation. https://buff.ly/2ZUWTiE
09/23/2020
Liver Transplantation During the COVID-19 Pandemic – Gastroenterology & Hepatology

Dr K. Rajender Reddy discusses the effects of the COVID-19 pandemic on liver transplantation. https://buff.ly/2ZUWTiE

Gastroenterology & Hepatology September 2020 - Volume 16, Issue 9 Liver Transplantation During the COVID-19 Pandemic K. Rajender Reddy, MD Ruimy Family President’s Distinguished Professor of Medicine Professor of Medicine in Surgery Director of Hepatology Medical Director, Liver Transplantation Un...

Sexual issues and fertility in male patients with IBD: a conversation with Dr Muhammad B. Hammmami. https://buff.ly/2S1G...
09/22/2020
Sexual Issues and Fertility in Male Patients With Inflammatory Bowel Disease – Gastroenterology & Hepatology

Sexual issues and fertility in male patients with IBD: a conversation with Dr Muhammad B. Hammmami. https://buff.ly/2S1GzIN

Gastroenterology & Hepatology September 2020 - Volume 16, Issue 9 Sexual Issues and Fertility in Male Patients With Inflammatory Bowel Disease Muhammad B. Hammami, MD Assistant Professor of Medicine Loma Linda University School of Medicine Health Sciences Assistant Clinical Professor University of C...

Drs Jessica Breton, Arthur Kastl, Maire A. Conrad, and Robert N. Baldassano review the efficacy and safety of biologic a...
08/14/2020
Positioning Biologic Therapies in the Management of Pediatric Inflammatory Bowel Disease – Gastroenterology & Hepatology

Drs Jessica Breton, Arthur Kastl, Maire A. Conrad, and Robert N. Baldassano review the efficacy and safety of biologic agents currently used in the treatment of pediatric IBD. https://buff.ly/2PGv5sN

Gastroenterology & Hepatology August 2020 - Volume 16, Issue 8 Positioning Biologic Therapies in the Management of Pediatric Inflammatory Bowel Disease Jessica Breton, MD, Arthur Kastl, MD, Maire A. Conrad, MD, and Robert N. Baldassano, MD Division of Gastroenterology, Hepatology, and Nutrition, Chi...

Dr Somashekar G. Krishna discusses the use of 3 novel endoscopic techniques for diagnosing pancreatic cysts: https://buf...
08/13/2020
Novel Endoscopic Techniques for the Diagnosis of Pancreatic Cysts – Gastroenterology & Hepatology

Dr Somashekar G. Krishna discusses the use of 3 novel endoscopic techniques for diagnosing pancreatic cysts: https://buff.ly/2XMF844

Gastroenterology & Hepatology August 2020 - Volume 16, Issue 8 Novel Endoscopic Techniques for the Diagnosis of Pancreatic Cysts Somashekar G. Krishna, MD, MPH Associate Professor of Medicine Division of Gastroenterology, Hepatology, and Nutrition The Ohio State University Wexner Medical Center Colu...

The relationship between the liver and the heart is explored in conversation with Dr Kalyan Ram Bhadmidimarri. https://b...
08/11/2020
Hepatic Complications and Liver Transplant in Congenital Cardiac Disease – Gastroenterology & Hepatology

The relationship between the liver and the heart is explored in conversation with Dr Kalyan Ram Bhadmidimarri. https://buff.ly/33JIJUb

Gastroenterology & Hepatology August 2020 - Volume 16, Issue 8 Hepatic Complications and Liver Transplant in Congenital Cardiac Disease Kalyan Ram Bhamidimarri, MD, MPH Associate Professor of Clinical Medicine Chief of Hepatology University of Miami Miami, Florida Download PDF G&H What is the curren...

Dr Brian Bressler discusses key findings from the EVOLVE study, which evaluated the use of vedolizumab and anti-TNF agen...
08/10/2020
Clinical Implications of Recent Findings From the EVOLVE Study – Gastroenterology & Hepatology

Dr Brian Bressler discusses key findings from the EVOLVE study, which evaluated the use of vedolizumab and anti-TNF agents in IBD patients who are naive to anti-TNF drugs. https://buff.ly/3fH38fb

Gastroenterology & Hepatology August 2020 - Volume 16, Issue 8 Clinical Implications of Recent Findings From the EVOLVE Study Brian Bressler, MD, MS Clinical Associate Professor of Medicine Division of Gastroenterology University of British Columbia Vancouver, British Columbia, Canada Download PDF G...

Artificial intelligence in gastroenterology: understanding imaging, text, and data with Dr Ryan W. Stidham. https://buff...
07/28/2020
Artificial Intelligence for Understanding Imaging, Text, and Data in Gastroenterology – Gastroenterology & Hepatology

Artificial intelligence in gastroenterology: understanding imaging, text, and data with Dr Ryan W. Stidham. https://buff.ly/39ftB1E

Gastroenterology & Hepatology July 2020 - Volume 16, Issue 7 Artificial Intelligence for Understanding Imaging, Text, and Data in Gastroenterology Ryan W. Stidham, MD, MS Ryan W. Stidham, MD, MS1,2,3 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michiga...

Dr Amanda M. Johnson and Dr Edward V. Loftus Jr review #obesity in patients with #IBD, including whether obesity affects...
07/27/2020
Impact of Obesity on the Management of Inflammatory Bowel Disease – Gastroenterology & Hepatology

Dr Amanda M. Johnson and Dr Edward V. Loftus Jr review #obesity in patients with #IBD, including whether obesity affects the pathogenesis, phenotype, treatment, or outcomes of IBD. https://buff.ly/3jyxqnB

Gastroenterology & Hepatology July 2020 - Volume 16, Issue 7 Impact of Obesity on the Management of Inflammatory Bowel Disease Amanda M. Johnson, MD, and Edward V. Loftus Jr, MD Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Mayo Clinic, Rochester, Minnesota Corresp...

Dr Jesus Rivera-Nieves on targeting beta-7 integrins in the management of #IBD: https://buff.ly/2ZP6yaI
07/24/2020
Targeting Beta-7 Integrins for the Treatment of Inflammatory Bowel Disease – Gastroenterology & Hepatology

Dr Jesus Rivera-Nieves on targeting beta-7 integrins in the management of #IBD: https://buff.ly/2ZP6yaI

Gastroenterology & Hepatology July 2020 - Volume 16, Issue 7 Targeting Beta-7 Integrins for the Treatment of Inflammatory Bowel Disease Jesus Rivera-Nieves, MD Professor of Medicine Division of Gastroenterology University of California, San Diego La Jolla, California Download PDF   G&H How and why ...

Dr Alan Bonder discusses the current first- and second-line therapies for primary biliary cholangitis, as well as data o...
07/24/2020
Current and Emerging Treatment Options for Primary Biliary Cholangitis – Gastroenterology & Hepatology

Dr Alan Bonder discusses the current first- and second-line therapies for primary biliary cholangitis, as well as data on PPARs, new FXR agonists, and combination therapy. https://buff.ly/2OKV9CA

Gastroenterology & Hepatology July 2020 - Volume 16, Issue 7 Current and Emerging Treatment Options for Primary Biliary Cholangitis Alan Bonder, MD Assistant Professor of Medicine Medical Director of Liver Transplantation Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachuse...

Dr Anthony J. Lembo explores the effects of placebo and nocebo in the setting of #IBS. https://buff.ly/2WFsLGA
07/23/2020
Understanding the Placebo and Nocebo Effects in Patients With Irritable Bowel Syndrome – Gastroenterology & Hepatology

Dr Anthony J. Lembo explores the effects of placebo and nocebo in the setting of #IBS. https://buff.ly/2WFsLGA

Gastroenterology & Hepatology July 2020 - Volume 16, Issue 7 Understanding the Placebo and Nocebo Effects in Patients With Irritable Bowel Syndrome Anthony J. Lembo, MD Associate Professor of Medicine Division of Gastroenterology Department of Medicine Beth Israel Deaconess Medical Center Harvard Me...

The risk of #NASH and progressive #fibrosis: Dr Mazen Noureddin discusses various demographic, laboratory, and histopath...
07/22/2020
Current Understanding of Risk for Nonalcoholic Steatohepatitis and Progressive Fibrosis – Gastroenterology & Hepatology

The risk of #NASH and progressive #fibrosis: Dr Mazen Noureddin discusses various demographic, laboratory, and histopathologic factors as well as recent research on African-American race, sex, genetics, and the microbiome in this area. https://buff.ly/39kTxJs

Gastroenterology & Hepatology July 2020 - Volume 16, Issue 7 Current Understanding of Risk for Nonalcoholic Steatohepatitis and Progressive Fibrosis Mazen Noureddin, MD, MHSc Director, Cedars-Sinai Fatty Liver Program Division of Digestive and Liver Diseases Comprehensive Transplant Center Cedars-Si...

Review the pros and cons of using radiofrequency ablation to treat Barrett’s esophagus with low-grade dysplasia.
08/31/2018
Radiofrequency Ablation for the Treatment of Barrett Esophagus With Low-Grade Dysplasia – Gastroenterology & Hepatology

Review the pros and cons of using radiofrequency ablation to treat Barrett’s esophagus with low-grade dysplasia.

Gastroenterology & Hepatology August 2018 - Volume 14, Issue 8 Radiofrequency Ablation for the Treatment of Barrett Esophagus With Low-Grade Dysplasia Herbert C. Wolfsen, MD Professor of Medicine Consultant in Gastroenterology Division of Gastroenterology and Hepatology Mayo Clinic Jacksonville Jack...

When it comes to HCV screening, ELISA plus PCR testing is the most cost-effective approach.
08/30/2018
Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus – Gastroenterology & Hepatology

When it comes to HCV screening, ELISA plus PCR testing is the most cost-effective approach.

Gastroenterology & Hepatology August 2018 - Volume 14, Issue 8 Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus Sammy Saab, MD, MPH, Timothy Ahn, BS, Terina McDaniel, RN, Beshoy Yanny, MD, and Myron J. Tong, PhD, MD Dr Saab is a professor in the Departments o...

Dr David E. Kaplan explores the use of statins in patients with cirrhosis.
08/29/2018
The Use of Statins in Patients With Cirrhosis – Gastroenterology & Hepatology

Dr David E. Kaplan explores the use of statins in patients with cirrhosis.

Gastroenterology & Hepatology August 2018 - Volume 14, Issue 8 The Use of Statins in Patients With Cirrhosis David E. Kaplan, MD, MSc Associate Professor of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania Download PDF   G&H Traditionally, what have ...

It may be beneficial to work in conjunction with allergist colleagues in the care of patients with eosinophilic esophagi...
08/28/2018
The Role of Allergy Testing in Eosinophilic Esophagitis – Gastroenterology & Hepatology

It may be beneficial to work in conjunction with allergist colleagues in the care of patients with eosinophilic esophagitis.

Gastroenterology & Hepatology August 2018 - Volume 14, Issue 8 The Role of Allergy Testing in Eosinophilic Esophagitis Adjoa Anyane-Yeboa, MD, Wenfei Wang, MD, and Robert T. Kavitt, MD, MPH Dr Anyane-Yeboa is a gastroenterology fellow and Dr Kavitt is an assistant professor of medicine and director....

Our editor-in-chief Dr Gary R. Lichtenstein explores the latest American College of Gastroenterology guideline for manag...
08/27/2018
Highlights From the New ACG Guideline on Crohn’s Disease Management – Gastroenterology & Hepatology

Our editor-in-chief Dr Gary R. Lichtenstein explores the latest American College of Gastroenterology guideline for managing Crohn’s disease.

Gastroenterology & Hepatology August 2018 - Volume 14, Issue 8 Highlights From the New ACG Guideline on Crohn’s Disease Management Gary R. Lichtenstein, MD Professor of Medicine Director, Center for Inflammatory Bowel Disease Perelman School of Medicine of the University of Pennsylvania Philadelph...

Drs Stephanie Gold, Shirley Cohen-Mekelburg, Yecheskel Schneider, and Adam Steinlauf discuss the anatomy and classificat...
08/24/2018
Perianal Fistulas in Patients With Crohn’s Disease, Part 1: Current Medical Management – Gastroenterology & Hepatology

Drs Stephanie Gold, Shirley Cohen-Mekelburg, Yecheskel Schneider, and Adam Steinlauf discuss the anatomy and classification of perianal fistulas as well as current medical therapies.

Gastroenterology & Hepatology August 2018 - Volume 14, Issue 8 Perianal Fistulas in Patients With Crohn’s Disease, Part 1: Current Medical Management Stephanie L. Gold, MD, Shirley Cohen-Mekelburg, MD, Yecheskel Schneider, MD, and Adam Steinlauf, MD Dr Gold is an internal medicine resident in the ...

What is an IBD medical home, and why is it needed for patient care?
08/23/2018
Medical Homes for Patients With Inflammatory Bowel Disease – Gastroenterology & Hepatology

What is an IBD medical home, and why is it needed for patient care?

Gastroenterology & Hepatology June 2017 - Volume Volume 13, Issue Issue 6 Medical Homes for Patients With Inflammatory Bowel Disease Miguel Regueiro, MD Professor of Medicine and Professor of Clinical and Translational Science University of Pittsburgh School of Medicine Senior Medical Lead of Specia...

Case study: patient with a serous microcystic adenoma of the pancreas.
08/23/2018
Serous Microcystic Adenoma of the Pancreas – Gastroenterology & Hepatology

Case study: patient with a serous microcystic adenoma of the pancreas.

Gastroenterology & Hepatology July 2017 - Volume Volume 13, Issue Issue 7 Serous Microcystic Adenoma of the Pancreas Diego Vázquez Saldaña, MD, David Antonio Mateo de Acosta Andino, MD, and Juan Pablo Gurria, MD Diego Vázquez Saldaña, MD: Division of Colorectal Surgery, Hospital General de Méxi...

Dr Ian S. Grimm discusses the use of peroral endoscopic myotomy in patients with esophageal disorders.
08/21/2018
Peroral Endoscopic Myotomy for the Management of Esophageal Disorders – Gastroenterology & Hepatology

Dr Ian S. Grimm discusses the use of peroral endoscopic myotomy in patients with esophageal disorders.

Gastroenterology & Hepatology July 2017 - Volume Volume 13, Issue Issue 7 Peroral Endoscopic Myotomy for the Management of Esophageal Disorders Ian S. Grimm, MD Professor of Medicine Director, GI Procedures Department of Medicine Division of Gastroenterology and Hepatology University of North Caroli...

A look at what the current literature reports regarding the possible increase of hepatocellular carcinoma after direct-a...
08/20/2018
Occurrence and Recurrence of Hepatocellular Carcinoma After Successful Direct-Acting Antiviral Therapy for Patients With Chronic Hepatitis C Virus Infection – Gastroenterology & Hepatology

A look at what the current literature reports regarding the possible increase of hepatocellular carcinoma after direct-acting antiviral therapy.

Gastroenterology & Hepatology July 2017 - Volume Volume 13, Issue Issue 7 Occurrence and Recurrence of Hepatocellular Carcinoma After Successful Direct-Acting Antiviral Therapy for Patients With Chronic Hepatitis C Virus Infection Sirisha Grandhe, MD, and Catherine T. Frenette, MD Dr Grandhe is a re...

How should alcoholic liver disease be treated?
08/17/2018
Treatment of Alcoholic Liver Disease – Gastroenterology & Hepatology

How should alcoholic liver disease be treated?

Gastroenterology & Hepatology July 2017 - Volume Volume 13, Issue Issue 7 Treatment of Alcoholic Liver Disease Timothy R. Morgan, MD Chief of Hepatology VA Long Beach Healthcare System Long Beach, California Professor of Medicine Division of Gastroenterology University of California, Irvine Irvine,....

An overview of the major therapeutic options for HCC and the evidence supporting them.
08/16/2018
Advances and Future Directions in the Treatment of Hepatocellular Carcinoma – Gastroenterology & Hepatology

An overview of the major therapeutic options for HCC and the evidence supporting them.

Gastroenterology & Hepatology July 2017 - Volume Volume 13, Issue Issue 7 Advances and Future Directions in the Treatment of Hepatocellular Carcinoma Ashil J. Gosalia, MD, Paul Martin, MD, and Patricia D. Jones, MD, MSCR Dr Gosalia is a gastroenterology fellow in the Department of Medicine at the Un...

Dr Francis A. Farraye discusses the importance of vaccinating IBD patients.
08/16/2018
Vaccination of Patients With Inflammatory Bowel Disease – Gastroenterology & Hepatology

Dr Francis A. Farraye discusses the importance of vaccinating IBD patients.

Gastroenterology & Hepatology July 2017 - Volume Volume 13, Issue Issue 7 Vaccination of Patients With Inflammatory Bowel Disease Francis A. Farraye, MD, MSc Professor of Medicine Boston University School of Medicine Boston, Massachusetts Download PDF   G&H How does the vaccination rate in patients...

Address

611 Broadway
New York, NY
10012

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

(212) 995-2211

Alerts

Be the first to know and let us send you an email when Gastroenterology & Hepatology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Gastroenterology & Hepatology:

Our Story

Gastroenterology & Hepatology (G&H) is a monthly peer-reviewed journal distributed to approximately 16,000 gastroenterologists and hepatologists. G&H provides editorial content encompassing a wide array of topics relevant and useful to the fields of gastroenterology and hepatology, both separately and together. Content is directed by the strong input of today’s top thought leaders in gastroenterology and hepatology, including feature-length review articles and monthly columns comprising engaging interviews with experts on current issues in inflammatory bowel disease, irritable bowel syndrome, gastroesophageal reflux disease, hepatitis, and endoscopy. G&H also publishes industry-supported Meeting Highlights, Clinical Roundtable Monographs, and Clinical Review Supplements. The journal and all affiliated supplements are included in the National Library of Medicine’s PubMed/MEDLINE index as well as EMBASE.

Nearby media companies


Other Media/News Companies in New York

Show All

Comments

hi
Is heart disease cause through kidney ailment? Date 29-11-2018 From Nalin Anhoni Pillai, Scientist To BBC World News –London Sir, I am surprise to see an article titled as “Heart disease tied to kidneys” appeared in ‘The Times of India’ dated 18-1-2011 stating that For the first time, an international team of scientists discovered a key kidney DNA sequence variant which plays a significant role in increasing the risk of heart failure. The DNA variant, a change in a single letter of the DNA sequence which is common in people, impairs channels that control kidney function, the researcher found. “It’s not a heart gene,” said Gerland Dorn from the Washington University School of Medicine in St Louis who is the lead author of the study. “It’s a kidney gene. This protein is not even expressed in the heart. Nobody has previously considered that kidney specific gene defects might predispose you to heart failure.” After analyzing both heart and the kidney, I would like to put it in a more perspective way how to avoid kidney disease as well as heart attacks solely cause by unpurified blood. In this context I had written a brief note regard to ‘Heart disease tied to kidneys’ is being displayed once again for all to read This DNA variant probably changes due to lack of electrical signal impairs the kidney tubules as well as Bowman’s capsules in filtering the blood. As a result of this partially unpurified blood get circulated and get deposited in the blood vessels itself. This may lead to coronary artery disease caused by kidney DNA variant affects the oxygen level in the heart ultimately it leads to heart failure. How to save human lives from renal disease to heart attacks? Saving human life is possible through the medium of light that increases the level of voltage in the brain that enhances the dipole dipole force which is nothing but Higgs Boson particles rendering them as candidate in carrying excess oxygen in their ionize blood cells. Further, it provides more oxygen for the heart and the kidney that enhances mitochondria to raise the energy level through photon transfer electrons. This excess energy regenerates the heart and the kidney that keeps other parameters level too in healthy condition. Thus it makes the body and the brain as fresh as ever through the medium of light. Regard to this I had already published a paper titled as “Secrets of the brain unraveled” about renal diseases which being subtitled as “Light help me to create this invisible growth acts as an excreta” can be assessed from this Website http://nalinsbrainresearch.blogspot.com/…/prevention-of-ren… Another paper titled as ‘Secrets of the brain unravelled’ which being subtitled as “How to prevent heart attacks in men and women” can be assessed from this Web site https://nalinsbrainresearch.blogspot.com/…/how-to-prevent-h… Let this beauty of light regenerates the heart and the kidney together. By Nalin Anthoni Pillai Brain Research Work Copy of this report posted to Society for Neuroscience” on 29-11-2018 Copy of this report posted to “Kings College London Neuroscience” on 29-11-2018 Copy of this report posted to “World Federation of Neurosurgical Societies” on 29-11-2018 Copy of this report posted to Dr. Jennifer Klay, Scientist –Asst Professor of Physics at California Polytechnic State University, San Luis Obispo Copy of this report posted to Federation of European Neuroscience (FENS)” on 29-11-2018 Copy of this report posted to Dr. Lawrence Krauss, Scientist from United States –California” on 29-11-2018 Copy of this report posted to “Neil Degrasse Tyson, Scientist from United States- New York” on 29-11-2018 Copy of this report posted to “Dr. Michio Kaku, Scientist from United States – California” on 29-11-2018 Copy of this report posted to “Design Call for “Solar Sentinel Mission –UK” on 29-11-2018 Copy of this report posted to “CERN Org. (LHC scientists in search for ‘Fifth force of nature” on 29-11-2018 Copy of this report posted to “NASA Crew and Thermal System Division – Space.Com” on 29-11-2018 Copy of this report posted to “Dr. Philip Plait, Scientist from United States –California” on 29-11-2018 Copy of this report posted to “Donald Trump –The President United States” on 29-11-2018 NCBI.NLM.NIH.GOV Can the World Federation of Neurosurgical Societies Classification Accurately Predict Outcomes in Intracerebral Hemorrhage? Many scoring systems have been developed for the purpose of estimating of mortality and outcomes in intracerebral hemorrhage (ICH). However, the
Dear Author, We are now accepting submissions. For details, please visit.